FDA
approval
· 2015-09-01
FDA Approved: DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE — Supplemental Application (Prasco Laboratories)
Summary
FDA approved a supplemental application for a fixed-dose combination of dapagliflozin and metformin hydrochloride, manufactured by Prasco Laboratories. The prod…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE (DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE)